Thomson Reuters (NASDAQ:TRI) executives said the company is positioned to benefit from rising compliance complexity and demand for specialized artificial intelligence tools, while pushing back on investor concerns that general-purpose AI models could erode its core legal, tax and accounting franchis
WhiteHorse Finance (NASDAQ:WHF) reported lower first-quarter earnings and a decline in net asset value as previously identified credit issues weighed on results, while management said share repurchases helped offset some of the impact through NAV accretion.
Chief Executive Officer Stuart Aronson sa
Wendy's (NASDAQ:WEN) reported first-quarter results that management said were largely in line with expectations, while acknowledging the restaurant chain remains in the early stages of a U.S. turnaround effort aimed at improving traffic, operations and franchisee economics.
Interim Chief Executive
Westrock Coffee (NASDAQ:WEST) reported sharply higher first-quarter 2026 results, with management saying the company has moved beyond a multiyear investment phase and is now operating as an integrated beverage platform.
Co-founder and Chief Executive Officer Scott Ford said the quarter marked “the
Vital Farms (NASDAQ:VITL) executives said the company’s first-quarter results and early second-quarter scanner data fell short of expectations as retail price gaps widened beyond levels the brand could sustain, prompting a reset of 2026 guidance and a series of cost and cash management actions.
Exe
Varex Imaging (NASDAQ:VREX) reported fiscal second-quarter revenue within its guidance range and said demand remained solid across its medical and industrial businesses, while management highlighted a completed debt refinancing and continued investment in advanced imaging technologies.
President an
Verastem (NASDAQ:VSTM) reported first-quarter 2026 net product revenue of $18.7 million for AVMAPKI FAKZYNJA CO-PACK, as management said the launch of the therapy for KRAS-mutated recurrent low-grade serous ovarian cancer continued to grow despite seasonal headwinds and some early commercial executi
Vertex (NASDAQ:VERX) reported first-quarter 2026 results above its guidance range and raised its full-year profitability outlook as management outlined a cost-reduction program intended to fund investments in e-invoicing, compliance and artificial intelligence.
The tax technology company posted fir
Upwork (NASDAQ:UPWK) said first-quarter 2026 results reflected a sharp shift in demand late in the period, as macroeconomic uncertainty and faster adoption of artificial intelligence weighed on lower-value work, while larger customer initiatives and AI-related projects continued to grow.
President
Vericel (NASDAQ:VCEL) reported record first-quarter revenue and raised its full-year 2026 outlook, citing strong growth across its MACI cartilage repair franchise and Burn Care business, as well as expected NexoBrid procurement revenue from a new federal contract.
President and Chief Executive Offi
Victory Capital (NASDAQ:VCTR) reported record first-quarter 2026 results, with executives pointing to higher gross flows, the contribution from the Pioneer acquisition and continued growth in its exchange-traded fund and international distribution platforms.
Chairman and CEO David Brown called the
Entrada Therapeutics (NASDAQ:TRDA) said initial data from the first cohort of its phase I/II ELEVATE-44-201 trial showed favorable safety and tolerability and early functional improvement in ambulatory patients with Duchenne muscular dystrophy, or DMD, who have mutations amenable to exon 44 skipping
TWFG (NASDAQ:TWFG) reported double-digit revenue and premium growth for the first quarter of 2026, with management pointing to acquisition contributions, organic growth and margin expansion from its managing general agency platform.
Founder, Chairman and CEO Gordy Bunch said the company delivered a
10x Genomics (NASDAQ:TXG) reported a first-quarter revenue increase excluding prior-year settlement revenue and used its earnings call to emphasize the launch of Atera, a new spatial biology instrument platform that management described as the most significant product introduction in the company’s h
Texas Roadhouse (NASDAQ:TXRH) executives said the company opened 2026 with strong sales and traffic gains, as first-quarter revenue surpassed $1.6 billion and comparable sales rose 7.1%.
Chief Executive Officer Jerry Morgan said the quarter was driven by 4.5% traffic growth, with guests continuing
Ultralife (NASDAQ:ULBI) reported a first-quarter loss for fiscal 2026 as lower sales, production disruptions and higher one-time costs weighed on results, even as management pointed to a record backlog and new product activity as signs of future growth.
President and CEO Mike Manna said the company
